1. Home
  2. NNNN vs MSB Comparison

NNNN vs MSB Comparison

Compare NNNN & MSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • MSB
  • Stock Information
  • Founded
  • NNNN 2021
  • MSB 1961
  • Country
  • NNNN Germany
  • MSB United States
  • Employees
  • NNNN N/A
  • MSB N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MSB Metal Mining
  • Sector
  • NNNN Health Care
  • MSB Basic Materials
  • Exchange
  • NNNN Nasdaq
  • MSB Nasdaq
  • Market Cap
  • NNNN 369.6M
  • MSB 318.2M
  • IPO Year
  • NNNN 2025
  • MSB N/A
  • Fundamental
  • Price
  • NNNN $49.26
  • MSB $25.08
  • Analyst Decision
  • NNNN
  • MSB
  • Analyst Count
  • NNNN 0
  • MSB 0
  • Target Price
  • NNNN N/A
  • MSB N/A
  • AVG Volume (30 Days)
  • NNNN 220.1K
  • MSB 35.2K
  • Earning Date
  • NNNN 01-01-0001
  • MSB 01-01-0001
  • Dividend Yield
  • NNNN N/A
  • MSB 27.37%
  • EPS Growth
  • NNNN N/A
  • MSB 335.65
  • EPS
  • NNNN 0.06
  • MSB 7.12
  • Revenue
  • NNNN $8,185,146.00
  • MSB $25,894,592.00
  • Revenue This Year
  • NNNN N/A
  • MSB N/A
  • Revenue Next Year
  • NNNN N/A
  • MSB N/A
  • P/E Ratio
  • NNNN $908.77
  • MSB $3.47
  • Revenue Growth
  • NNNN 21.95
  • MSB N/A
  • 52 Week Low
  • NNNN $5.18
  • MSB $15.93
  • 52 Week High
  • NNNN $53.11
  • MSB $37.00
  • Technical
  • Relative Strength Index (RSI)
  • NNNN N/A
  • MSB 52.13
  • Support Level
  • NNNN N/A
  • MSB $24.00
  • Resistance Level
  • NNNN N/A
  • MSB $25.48
  • Average True Range (ATR)
  • NNNN 0.00
  • MSB 1.01
  • MACD
  • NNNN 0.00
  • MSB 0.18
  • Stochastic Oscillator
  • NNNN 0.00
  • MSB 81.09

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About MSB Mesabi Trust

Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of its assets. The company's principally wholly-owned segment is the iron ore mining segment, which generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.

Share on Social Networks: